Role of Radiotherapy in Liver Tumors: Recent Update

[1] Yang Y, Xiong L, Li M, Jiang P, Wang J, Li C. Advances in radiotherapy and immunity in hepatocellular carcinoma. Vol. 21, Journal of Translational Medicine. BioMed Central Ltd; 2023. YangY XiongL LiM JiangP WangJ LiC Advances in radiotherapy and immunity in hepatocellular carcinoma 21 Journal of Translational Medicine BioMed Central Ltd 2023 Search in Google Scholar

[2] Watson J, Hydon K, Lodge P. Primary and secondary liver tumours. InnovAiT: Education and inspiration for general practice. 2016 Aug;9(8):477–82. WatsonJ HydonK LodgeP Primary and secondary liver tumours InnovAiT: Education and inspiration for general practice 2016 Aug 9 8 477 82 Search in Google Scholar

[3] Amini M, Looha MA, Zarean E, Pourhoseingholi MA. Global pattern of trends in incidence, mortality, and mortality-to-incidence ratio rates related to liver cancer, 1990–2019: a longitudinal analysis based on the global burden of disease study. BMC Public Health. 2022 Dec 1;22(1). AminiM LoohaMA ZareanE PourhoseingholiMA Global pattern of trends in incidence, mortality, and mortality-to-incidence ratio rates related to liver cancer, 1990–2019: a longitudinal analysis based on the global burden of disease study BMC Public Health 2022 Dec 1 22 1 Search in Google Scholar

[4] Rumgay H, Ferlay J, de Martel C, Georges D, Ibrahim AS, Zheng R, et al. Global, regional and national burden of primary liver cancer by subtype. Eur J Cancer. 2022 Jan;161:108–18. RumgayH FerlayJ de MartelC GeorgesD IbrahimAS ZhengR Global, regional and national burden of primary liver cancer by subtype Eur J Cancer 2022 Jan 161 108 18 Search in Google Scholar

[5] Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023 Aug;79(2):516–37. DevarbhaviH AsraniSK ArabJP NarteyYA PoseE KamathPS Global burden of liver disease: 2023 update J Hepatol 2023 Aug 79 2 516 37 Search in Google Scholar

[6] Sadikin BG. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Karsinoma Sel Hati Pada Dewasa. 1st ed. Vol. 1. Jakarta: Keputusan Menteri Kesehatan Republik Indonesia; 2022. 1–122 p. SadikinBG Pedoman Nasional Pelayanan Kedokteran Tata Laksana Karsinoma Sel Hati Pada Dewasa 1st ed. 1 Jakarta Keputusan Menteri Kesehatan Republik Indonesia 2022 1 122 Search in Google Scholar

[7] Cancer Today [Internet]. [cited 2024 Feb 22]. Available from: https://gco.iarc.fr/today/en Cancer Today [Internet] [cited 2024 Feb 22]. Available from: https://gco.iarc.fr/today/en Search in Google Scholar

[8] Liver Cancer Treatment - NCI [Internet]. [cited 2024 Feb 22]. Available from: https://www.cancer.gov/types/liver/what-is-liver-cancer/treatment Liver Cancer Treatment - NCI [Internet] [cited 2024 Feb 22]. Available from: https://www.cancer.gov/types/liver/what-is-liver-cancer/treatment Search in Google Scholar

[9] Benson AB, D’Angelica MI, Abrams T, Abbott DE, Ahmed A, Anaya DA, et al. NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023. Journal of the National Comprehensive Cancer Network. 2023 Jul;21(7):694–704. BensonAB D’AngelicaMI AbramsT AbbottDE AhmedA AnayaDA NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023 Journal of the National Comprehensive Cancer Network 2023 Jul 21 7 694 704 Search in Google Scholar

[10] Chen CP. Role of radiotherapy in the treatment of hepatocellular carcinoma. Vol. 7, Journal of Clinical and Translational Hepatology. Xia and He Publishing Inc.; 2019. p. 183–90. ChenCP Role of radiotherapy in the treatment of hepatocellular carcinoma 7 Journal of Clinical and Translational Hepatology Xia and He Publishing Inc. 2019 183 90 Search in Google Scholar

[11] Chen LC, Lin HY, Hung SK, Chiou WY, Lee MS. Role of modern radiotherapy in managing patients with hepatocellular carcinoma. Vol. 27, World Journal of Gastroenterology. Baishideng Publishing Group Co; 2021. p. 2434–57. ChenLC LinHY HungSK ChiouWY LeeMS Role of modern radiotherapy in managing patients with hepatocellular carcinoma 27 World Journal of Gastroenterology Baishideng Publishing Group Co 2021 2434 57 Search in Google Scholar

[12] Kimura T, Fujiwara T, Kameoka T, Adachi Y, Kariya S. The Current Role of Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma (HCC). Vol. 14, Cancers. MDPI; 2022. KimuraT FujiwaraT KameokaT AdachiY KariyaS The Current Role of Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma (HCC) 14 Cancers MDPI 2022 Search in Google Scholar

[13] Gordan JD, Kennedy EB, Ghassan ;, Abou-Alfa K, Muhammad ;, Beg S, et al. Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline. J Clin Oncol [Internet]. 2020;38:4317–45. Available from: https://doi. GordanJD KennedyEB Ghassan Abou-AlfaK Muhammad BegS Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline J Clin Oncol [Internet] 2020 38 4317 45 Available from: https://doi. Search in Google Scholar

[14] Vogel A, Martinelli E, Cervantes A, Chau I, Daniele B, Llovet JM, et al. Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines. Vol. 32, Annals of Oncology. Elsevier Ltd; 2021. p. 801–5. VogelA MartinelliE CervantesA ChauI DanieleB LlovetJM Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines 32 Annals of Oncology Elsevier Ltd 2021 801 5 Search in Google Scholar

[15] Rio E, Mornex F, Maingon P, Peiffert D, Parent L. Hepatic tumours and radiotherapy. Cancer Radiother. 2022;26(1–2):266–71. RioE MornexF MaingonP PeiffertD ParentL Hepatic tumours and radiotherapy Cancer Radiother 2022 26 1–2 266 71 Search in Google Scholar

[16] Hunte SO, Clark CH, Zyuzikov N, Nisbet A. Volumetric modulated arc therapy (VMAT): a review of clinical outcomes—what is the clinical evidence for the most effective implementation? Vol. 95, British Journal of Radiology. British Institute of Radiology; 2022. HunteSO ClarkCH ZyuzikovN NisbetA Volumetric modulated arc therapy (VMAT): a review of clinical outcomes—what is the clinical evidence for the most effective implementation? 95 British Journal of Radiology British Institute of Radiology 2022 Search in Google Scholar

[17] Koay EJ, Owen D, Das P. Radiation-Induced Liver Disease and Modern Radiotherapy. Vol. 28, Seminars in Radiation Oncology. W.B. Saunders; 2018. p. 321–31. KoayEJ OwenD DasP Radiation-Induced Liver Disease and Modern Radiotherapy 28 Seminars in Radiation Oncology W.B. Saunders 2018 321 31 Search in Google Scholar

[18] Kalogeridi MA, Zygogianni A, Kyrgias G, Kouvaris J, Chatziioannou S, Kelekis N, et al. Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review. World J Hepatol. 2015;7(1):101–12. KalogeridiMA ZygogianniA KyrgiasG KouvarisJ ChatziioannouS KelekisN Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review World J Hepatol 2015 7 1 101 12 Search in Google Scholar

[19] Petrowsky H, Fritsch R, Guckenberger M, De Oliveira ML, Dutkowski P, Clavien PA. Modern therapeutic approaches for the treatment of malignant liver tumours. Vol. 17, Nature Reviews Gastroenterology and Hepatology. Nature Research; 2020. p. 755–72. PetrowskyH FritschR GuckenbergerM De OliveiraML DutkowskiP ClavienPA Modern therapeutic approaches for the treatment of malignant liver tumours 17 Nature Reviews Gastroenterology and Hepatology Nature Research 2020 755 72 Search in Google Scholar

[20] Navin PJ, Olson MC, Mendiratta-Lala M, Hallemeier CL, Torbenson MS, Venkatesh SK. Imaging Features in the Liver after Stereotactic Body Radiation Therapy. Radiographics. 2022;42(7):2131–48. NavinPJ OlsonMC Mendiratta-LalaM HallemeierCL TorbensonMS VenkateshSK Imaging Features in the Liver after Stereotactic Body Radiation Therapy Radiographics 2022 42 7 2131 48 Search in Google Scholar

[21] Muhammad H, Tehreem A, Ting PS, Gurakar M, Li SY, Simsek C, et al. Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review. J Clin Transl Hepatol. 2021;9(5):738–48. MuhammadH TehreemA TingPS GurakarM LiSY SimsekC Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review J Clin Transl Hepatol 2021 9 5 738 48 Search in Google Scholar

[22] Shimamura T, Goto R, Watanabe M, Kawamura N, Takada Y. Liver Transplantation for Hepatocellular Carcinoma: How Should We Improve the Thresholds? 2022; Available from: https://doi.org/10.3390/cancers14020419 ShimamuraT GotoR WatanabeM KawamuraN TakadaY Liver Transplantation for Hepatocellular Carcinoma: How Should We Improve the Thresholds? 2022 Available from: https://doi.org/10.3390/cancers14020419 Search in Google Scholar

[23] Kim N, Kim HJ, Won JY, Kim DY, Han KH, Jung I, et al. Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma. Radiother Oncol. 2019 Feb;131:81–7. KimN KimHJ WonJY KimDY HanKH JungI Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma Radiother Oncol 2019 Feb 131 81 7 Search in Google Scholar

[24] Wahl DR, Stenmark MH, Tao Y, Pollom EL, Caoili EM, Lawrence TS, et al. Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma. Journal of Clinical Oncology. 2016 Feb 10;34(5):452–9. WahlDR StenmarkMH TaoY PollomEL CaoiliEM LawrenceTS Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma Journal of Clinical Oncology 2016 Feb 10 34 5 452 9 Search in Google Scholar

[25] Bae SH, Chun SJ, Chung JH, Kim E, Kang JK, Jang W Il, et al. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines. International Journal of Radiation Oncology Biology Physics. Elsevier Inc.; 2023. BaeSH ChunSJ ChungJH KimE KangJK JangW Il Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines International Journal of Radiation Oncology Biology Physics Elsevier Inc. 2023 Search in Google Scholar

[26] Sapisochin G, Barry A, Doherty M, Fischer S, Goldaracena N, Rosales R, et al. Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis. J Hepatol. 2017 Jul 1;67(1):92–9. SapisochinG BarryA DohertyM FischerS GoldaracenaN RosalesR Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis J Hepatol. 2017 Jul 1 67 1 92 9 Search in Google Scholar

[27] Dumago MP, Agas RAF, Jainar CJE, Yap ET, Co LBA, Ortin TTS. Stereotactic Body Radiation Therapy With or Without Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone in Early-Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. J Gastrointest Cancer. 2023 Dec;54(4):1058–70. DumagoMP AgasRAF JainarCJE YapET CoLBA OrtinTTS Stereotactic Body Radiation Therapy With or Without Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone in Early-Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis J Gastrointest Cancer 2023 Dec 54 4 1058 70 Search in Google Scholar

[28] Wong TC, Chiang CL, Lee AS, Lee VH, Yeung CS, Ho CH, et al. Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis. Surg Oncol. 2019 Mar;28:228–35. WongTC ChiangCL LeeAS LeeVH YeungCS HoCH Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis Surg Oncol 2019 Mar 28 228 35 Search in Google Scholar

[29] Shen L, Xi M, Zhao L, Zhang X, Wang X, Huang Z, et al. Combination therapy after TACE for hepatocellular carcinoma with macroscopic vascular invasion: Stereotactic body radiotherapy versus sorafenib. Cancers (Basel). 2018 Dec 1;10(12). ShenL XiM ZhaoL ZhangX WangX HuangZ Combination therapy after TACE for hepatocellular carcinoma with macroscopic vascular invasion: Stereotactic body radiotherapy versus sorafenib Cancers (Basel) 2018 Dec 1 10 12 Search in Google Scholar

[30] Yoon SM, Ryoo BY, Lee SJ, Kim JH, Shin JH, An JH, et al. Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion : A randomized clinical trial. In: JAMA Oncology. American Medical Association; 2018. p. 661–9. YoonSM RyooBY LeeSJ KimJH ShinJH AnJH Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion : A randomized clinical trial In: JAMA Oncology American Medical Association 2018 661 9 Search in Google Scholar

[31] Rim CH, Lee JS, Kim SY, Seong J. Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis. JHEP Reports. 2023 Jan 1;5(1). RimCH LeeJS KimSY SeongJ Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis JHEP Reports 2023 Jan 1 5 1 Search in Google Scholar

[32] Yamamoto M, Yoshida M, Furuse J, Sano K, Ohtsuka M, Yamashita S, et al. Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021. J Hepatobiliary Pancreat Sci. 2021 Jan 1;28(1):1–25. YamamotoM YoshidaM FuruseJ SanoK OhtsukaM YamashitaS Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021 J Hepatobiliary Pancreat Sci 2021 Jan 1 28 1 1 25 Search in Google Scholar

[33] Yoo GS, Rim CH, Cho WK, Jeong JU, Chie EK, Cho HM, et al. Metastasis-Directed Local Therapy of Hepatic Oligometastasis from Colorectal Cancer and Future Perspective in Radiation Therapy. Cancer Res Treat. 2023 Jul 1;55(3):707–19. YooGS RimCH ChoWK JeongJU ChieEK ChoHM Metastasis-Directed Local Therapy of Hepatic Oligometastasis from Colorectal Cancer and Future Perspective in Radiation Therapy Cancer Res Treat 2023 Jul 1 55 3 707 19 Search in Google Scholar

[34] Jackson WC, Tao Y, Mendiratta-Lala M, Bazzi L, Wahl DR, Schipper MJ, et al. Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases. Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):950–8. JacksonWC TaoY Mendiratta-LalaM BazziL WahlDR SchipperMJ Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases Int J Radiat Oncol Biol Phys 2018 Mar 15 100 4 950 8 Search in Google Scholar

[35] Yu J, Kim DH, Lee J, Shin YM, Kim JH, Yoon SM, et al. Radiofrequency Ablation versus Stereotactic Body Radiation Therapy in the Treatment of Colorectal Cancer Liver Metastases. Cancer Res Treat. 2022 Jul 1;54(3):850–9. YuJ KimDH LeeJ ShinYM KimJH YoonSM Radiofrequency Ablation versus Stereotactic Body Radiation Therapy in the Treatment of Colorectal Cancer Liver Metastases Cancer Res Treat 2022 Jul 1 54 3 850 9 Search in Google Scholar

[36] Méndez Romero A, Schillemans W, van Os R, Koppe F, Haasbeek CJ, Hendriksen EM, et al. The Dutch–Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases. Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1377–86. Méndez RomeroA SchillemansW van OsR KoppeF HaasbeekCJ HendriksenEM The Dutch–Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases Int J Radiat Oncol Biol Phys 2021 Apr 1 109 5 1377 86 Search in Google Scholar

[37] de la Peña C, Gonzalez MF, González C, Salazar JM, Cruz B. Stereotactic body radiation therapy for liver metastases: Clinical outcomes and literature review. Reports of Practical Oncology and Radiotherapy. 2020 Jul 1;25(4):637–42. de la PeñaC GonzalezMF GonzálezC SalazarJM CruzB Stereotactic body radiation therapy for liver metastases: Clinical outcomes and literature review Reports of Practical Oncology and Radiotherapy 2020 Jul 1 25 4 637 42 Search in Google Scholar

[38] Palma DA, Olson R, Harrow S, Gaede S, Louie A V., Haasbeek C, et al. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: Long-term results of the SABR-COMET Phase II randomized trial. Journal of Clinical Oncology. 2020;38(25):2830–8. PalmaDA OlsonR HarrowS GaedeS LouieA V. HaasbeekC Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: Long-term results of the SABR-COMET Phase II randomized trial Journal of Clinical Oncology 2020 38 25 2830 8 Search in Google Scholar

[39] Lee JW, Choi MH, Lee YJ, Ali B, Yoo HM, Song KY, et al. Radiofrequency ablation for liver metastases in patients with gastric cancer as an alternative to hepatic resection. BMC Cancer. 2017 Mar 10;17(1). LeeJW ChoiMH LeeYJ AliB YooHM SongKY Radiofrequency ablation for liver metastases in patients with gastric cancer as an alternative to hepatic resection BMC Cancer 2017 Mar 10 17 1 Search in Google Scholar